EVALUATION OF HEPATOCYTE GROWTH-PROMOTING FACTORS IN TREATING 1687 CASES OF FULMINANT HEPATITIS

Fulminant hepatitis is a serious and complex disease with high mortality. In recent years, hepatocyte growth-promoting factors (pHGF), developed on the basis of fetal liver cell injection, has been jointly used as a comprehensive therapy for fulminant hepatitis. The following is a report of the results of using pHGF for the treatment of 1687 cases of fulminant hepatitis (with 1196 controls).

甘利欣联合促肝细胞生长素治疗慢性乙型肝炎的疗效观察

目的 观察注射用甘利欣联合促肝细胞生长素治疗慢性乙型肝炎的临床疗效。方法 治疗组用甘利欣联合促肝细胞生长素 ,对照组单用甘利欣 ,治疗 2 8天 ,观察治疗效果。结果 两组的显效率分别为 61.9%和 3 3 .3 3 %、总有效率分别为 95 .2 3 %和 85 .71% (P <0 .0 5 ) ,治疗组的临床疗效明显优于对照组。